Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CELZ is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
1 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
13 filers reported a long position in CELZ for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Hudson Bay Capital Management LP | $196K | 135.2K | New |
| Anson Funds Management LP | $153K | 105.5K | New |
| ARMISTICE CAPITAL, LLC | $60.9K | 42K | New |
| XTX Topco Ltd | $38.5K | 26.6K | +86.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $37.4K | 25.8K | -32.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.5K | 20.4K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $8K | 5.5K | Unchanged |
| Tower Research Capital LLC (TRC) | $7K | 4.9K | +132% |
| Global Retirement Partners, LLC | $6K | 4.1K | — |
| UBS Group AG | $3K | 2.1K | +206,000% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.